Swedish-based investment firm EQT, has agreed with QIAGEN, a Netherlands-based provider of sample and assay technologies for ...

Spain-based low/mid-market investor, Buenavista Equity Partners, has acquired 71.2% stake in Tiryaq Medical Group, a Spanish ...

The distinction is important for sellers. Strategic interest is returning, but buyers are becoming more selective about the assets they pursue and the prices they are willing to pay.

ARCHIMED’s Healthcare IT team has acquired a majority stake in 3verest, a UK-based healthcare-dedicated private, sovereign ...

Solabia, a France-based manufacturer of natural active ingredients owned by Astorg, a pan-European private equity firm, is to ...

Centric Health, and Ireland-based provider of primary care, is being acquired by US-based Healthspan Partners, according to ...

Capital Dynamics, a global private asset management firm, has joined CareHub’s shareholder base. CareHub is a platform ...

Nouscom is developing neoantigen-targeted immunotherapies for cancer at all stages, built on a proprietary viral vector ...

Merck KGaA, a German-based science and technology company operating across life science, healthcare and electronics, has ...

OrbiMed, a US-based global healthcare investment firm, has raised US$3bn in commitments across two new private equity funds, ...

Creadev, a French investment company owned by the Mulliez family, has acquired a majority stake in Groupe Santé Basque Développement, a French-based operator of psychiatric clinics and day hospitals, ...

AL-S Pharma’s lead programme, AP-101, is a human monoclonal antibody targeting misfolded superoxide dismutase 1 (SOD1). The ...